Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Robin Blume

Nurse Practitioner Beckley, WV Nurse Practitioner

NPI 1144539750 CMS profile 10703918

1710 Harper Rd, Beckley, WV 25801

Open in the dashboard

General payments

$18,369

1,037 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robin Blume of Beckley, WV is reported in the CMS Open Payments database as having received $18,369 across 1,037 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,371 239
2024 General $4,388 229
2023 General $3,762 201
2022 General $3,004 184
2021 General $2,844 184

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robin Blume
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Robin Blume were reported at $4,371. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Robin Blume Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $2,844 $135 $40–$426 $132
2022 $3,004 $152 $48–$470 $149
2023 $3,762 $166 $54–$529 $160
2024 $4,388 $173 $55–$556 $164
2025 $4,371 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $3,012 171 payments
  2. Alexion Pharmaceuticals, Inc. $1,675 58 payments
  3. Pfizer Inc. $1,439 117 payments
  4. UCB, Inc. $1,275 80 payments
  5. Teva Pharmaceuticals USA, Inc. $1,092 64 payments
  6. Biogen, Inc. $864 50 payments
  7. Novartis Pharmaceuticals Corporation $852 49 payments
  8. SK Life Science, Inc. $718 36 payments
  9. Argenx US, Inc. $709 31 payments
  10. Neurelis, Inc. $515 29 payments
  11. Other $6,218 352 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $17,715 1,026 payments
  2. Education $654 11 payments
Products named General payments · program years 2021–2025
  1. UBRELVY $1,983 121 payments
  2. QULIPTA $1,909 109 payments
  3. NURTEC ODT Pain $1,439 117 payments
  4. ZAVZPRET $1,303 109 payments
  5. ULTOMIRIS $985 35 payments
  6. NURTEC ODT Primary Care $792 57 payments
  7. Briviact $698 48 payments
  8. VYVGART Hytrulo $551 23 payments
  9. KESIMPTA $517 27 payments
  10. VALTOCO $515 29 payments
  11. Other $10,069 577 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,037 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record